Dr. Wenhua Yu is a seasoned intellectual property attorney specializing in the life sciences industry. With over 12 years of experience, she helps clients—from biotech startups to multinational pharmaceutical companies—maximize IP protection and leverage intellectual property to enhance business strategies and transactions. Her expertise spans global patent strategy, portfolio development, IP due diligence, and partnership negotiations.

She excels at crafting tailored IP and patent strategies by collaborating closely with scientific teams to ensure alignment between patenting efforts and therapeutic pipeline development. Her deep technical knowledge covers immunotherapies, gene and cell therapies, vaccines, small-molecule drugs, conjugated therapeutics, as well as manufacturing and delivery technologies such as vectors and lipid nanoparticles.She has provided extensive legal advice supporting R&D, IP, and business strategies for industry leaders like BMS/Celgene, Merck & Co., and Johnson & Johnson, and has worked on multiple commercialized prod ucts.

She also has over eight years of experience advising on technology transactions and partnership strate gies, including structuring, negotiating, and drafting licensing and collaboration agreements for biotech and pharmaceutical clients. She supports clients in post-agreement relationship management and resolv ing IP-related disputes. She has represented clients in cross-border transactions between the U.S. and Asian markets.